PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 7, 2026Diabetes

3016-LB: Overexpression of Immune Inhibitory Ligand B7-H4, Not PD-L1, on Pancreatic Beta Cells Confer Resistance to Type 1 Diabetes in NOD Mice

View Full Paper
Ask AI
Bookmark
Share

Authors

OWOrr-El WeizmanQSQI SURBRYAN E. BUCKTROUT

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates B7-H4's protective role against type 1 diabetes in NOD mice, indicating potential treatment strategies.

Key Points

  • This study aims to evaluate the role of immune inhibitory ligands B7-H4 and PD-L1 in protecting pancreatic β cells from destruction by T cells in a mouse model of type 1 diabetes.
  • Transgenic NOD mice expressing B7-H4 or PD-L1 in β cells were generated.
  • Mice were monitored for diabetes incidence weekly until 30 weeks of age, defined by glucose levels.
  • Immune profiling was conducted using scRNAseq and flow cytometry during peak insulitis at ~12 weeks.
  • NODB7H4 mice exhibited reduced diabetic incidence (2/20 mice; p=0.002) compared to NODWT.
  • NODPDL1 mice did not show delayed onset of diabetes.
  • NODB7H4 mice displayed a reduction of activated effector CD8+ T cells and downregulation of immune response pathways.

Cite This Study

Weizman et al. (2026) studied this question.

synapsesocial.com/papers/6a250ac07def13d035e1ace0https://doi.org/10.2337/db26-3016-lb
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 11061-OR: N-104, Next-Gen Dual-Action Immunoregulatory and Regenerative Therapy for Type 1 Diabetes2026
  2. 2124-OR: Intervention of Select Lipid Signaling Reduces Type 1 Diabetes Incidence2024
  3. 36413 Anti-PD1 induces T1D in an HLA-DQ8, HLA-A2.1 mouse model2024
  4. 41084-OR: PanKbase Integrated Pancreatic Islet Single-Cell Map: A Comprehensive Resource with New Insights into Diabetes2026
  5. 51168-OR: Pancreas-Targeted Glucagon-Like Peptide 1 Gene Therapy Enhances β-Cell Function and Suppresses Cellular Stress in Preclinical Type 2 Diabetes Models2026